• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of inflammasome and ASC in pancreatic adenocarcinoma progression

Research Project

Project/Area Number 18K15819
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionEhime University

Principal Investigator

Koizumi Mitsuhito  愛媛大学, 医学部附属病院, 講師(病院教員) (40748307)

Project Period (FY) 2018-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2019: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords膵癌 / ASC
Outline of Final Research Achievements

Although molecular targeted therapies for pancreatic ductal adenocarcinoma (PDAC) have been developed, their therapeutic effects are not sufficient and new therapeutic targets are warranted. In this study, we focused on inflammasome, a protein complex that plays a central role in inflammation, and its important constituent protein, apoptosis-associated speck-like protein containing a CARD (ASC). Compared with other inflammasome constituent proteins, ASC was expressed more in PDAC tissues than in the noncancerous pancreatic tissues. ASCs were expressed in multiple PDAC cell lines as compared to pancreatic ductal epithelial cells. Reducing ASCs of PDAC cell lines suppressed cell growth of cancer cells. This study revealed that ASC contributes to the growth of PDAC. Our findings may lead to the establishment of a new therapeutic method targeting ASC in PDAC.

Academic Significance and Societal Importance of the Research Achievements

膵癌に対する分子標的治療が開発されているが、その治療効果は十分ではなく、新しい治療ターゲットの確立が必要である。本研究により、ASCが膵癌の増殖に寄与していることが明らかになった。膵癌においてASCを標的とした新しい治療法の確立につながると考えられた。

Report

(3 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • Research Products

    (3 results)

All 2020 2019

All Journal Article (2 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (1 results)

  • [Journal Article] ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer2020

    • Author(s)
      Tanaka Y, Kumagi T, Terao T, Kuroda T, Yokota T, Azemoto N, Imamura Y, Uesugi K, Kisaka Y, Shibata N, Koizumi M, Ohno Y, Kanemitsu K, Yukimoto A, Tange K, Nishiyama M, Miyake T, Miyata H, Ishii H, Abe M, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group.
    • Journal Title

      Internal Medicine

      Volume: 59 Issue: 6 Pages: 761-768

    • DOI

      10.2169/internalmedicine.3748-19

    • NAID

      130007808818

    • ISSN
      0918-2918, 1349-7235
    • Year and Date
      2020-03-15
    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance2019

    • Author(s)
      Kumagi T, Terao T, Yokota T, Azemoto N, Kuroda T, Imamura Y, Uesugi K, Kisaka Y, Tanaka Y, Shibata N, Koizumi M, Ohno Y, Yukimoto A, Tange K, Nishiyama M, Kanemitsu K, Miyake T, Miyata H, Ishii H, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group.
    • Journal Title

      Mayo Clinic Proceedings

      Volume: 94 Issue: 10 Pages: 2004-2010

    • DOI

      10.1016/j.mayocp.2018.12.034

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] 膵癌におけるインフラマソーム・ASCの役割2019

    • Author(s)
      小泉光仁,今村良樹,兼光梢,黒田太良,渡辺崇夫, 熊木天児,阿部雅則,日浅 陽一
    • Organizer
      第112回日本消化器病学会四国支部例会
    • Related Report
      2019 Annual Research Report

URL: 

Published: 2018-04-23   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi